What’s Next for Pharma? Experts from the Tufts Center for the Study of Drug Development discuss the outlook for R&D, mergers, and the FDA’s changing role
Name *
E-mail *
Web site
Comment
Discussion
No comments for “What’s Next for Pharma?”
Post a comment